- Sarepta Therapeutics Announces Voluntary Pause of ELEVIDYS Shipments in the U.S. Sarepta Therapeutics
- In surprise reversal, Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy statnews.com
- Sarepta LGMD trials all hit by FDA hold amid newly surfaced safety concerns over gene therapy Fierce Biotech
- Sarepta shares plunge 40% as future of its gene therapy appears at risk CNBC
- Sarepta Therapeutics stock sinks after FDA tells company to stop shipping its bestselling drug Yahoo Finance
Source link
